| Clinical data | |
|---|---|
| Other names | LY-79907; 2-Chloro-6-methylergoline-8β-acetonitrile |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H18ClN3 |
| Molar mass | 299.80 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Lergotrile (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name) is anergolinederivative which acts as adopamine receptor agonist. It was developed for the treatment ofParkinson's disease, but failed inclinical trials due toliver toxicity.[1][2]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |